Brian T. Tsuji

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 931 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Roger L. Nation, Jian Li, Otto Cars et al. · The Lancet Infectious Diseases · 2014 · 343 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +15

Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium

George Sakoulas, Arnold S. Bayer, Joseph Pogliano et al. · Antimicrobial Agents and Chemotherapy · 2011 · 174 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Pharmacokinetic/Pharmacodynamic Investigation of Colistin against <i>Pseudomonas aeruginosa</i> Using an <i>In Vitro</i> Model

Phillip J. Bergen, Jürgen B. Bulitta, Alan Forrest et al. · Antimicrobial Agents and Chemotherapy · 2010 · 168 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models

Cornelia B. Landersdorfer, Jiping Wang, Veronika Wirth et al. · Journal of Antimicrobial Chemotherapy · 2017 · 138 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17